Pfizer�s $PFE top-line was up 8%, Y-o-Y for the FYQ3 but net income plunged 38%. For FY2016, guidance is: revenue of $52 billion to $53 billion from $51 billion and $53 billion. Non-GAAP EPS guidance is of $2.38 to $2.43 from $2.38 - $2.48.